Independent CRISPR/Cas9 (Oser et al., 2019) and drug screening assays (Gong et al., 2019) using Rb1-deficient classical SCLC cell lines simultaneously identified a unique dependence upon AURK for survival. This evidence concerns the gene RB1 and small cell lung carcinoma.